Screener
Claseprubart Program Related Expenses
Dianthus Therapeutics·Products & Services·3 segments
Breakdown
Segments
Clinical Operation ActivitiesView metric
CMC ActivitiesView metric
Preclinical Study Activity CostsView metric
| Segment | Q1 '26 |
|---|---|
| Clinical Operation Activities | $14.16M |
| CMC Activities | $3.71M |
| Preclinical Study Activity Costs | $320K |
| Total | $14.16M |